While the test primarily assesses GLP-1 receptor, GIPR, FTO, and MC4R variants related to medication response, understanding your broader metabolic profileincluding factors like inflammation and glucose regulationmay inform your provider's injection strategy and timeline adjustments
Technically yes, but it is strongly discouraged
You may wonder how Trulicity compares with other drugs used to treat diabetes
0.50 Gifts with all orders over 20 Developed and endorsed by experts Trusted by Customers
Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora LK
The FDA-approved prescribing information for tirzepatide states that the medication can be administered at any time of day, with or without meals, providing significant flexibility for patients